Loading...

ADGM ADAGIO MEDICAL HOLDINGS INC US FDA Inspections 8-K Filing

DG M

DGM

ADAGIO MEDICAL HOLDINGS INC

(ADGM)

2026 8-K

FDA Application Submitted

Financial Results Announced

Positive Results Announcement

Annual Meeting Notice

FDA Approval Granted

Financial Results Update

Annual Meeting Results

Quarterly Results

Annual Meeting Announcement

Private Placement Closed

Securities Agreement

Study Results Released

Enrollment Complete

CFO Appointment

Financial Update

Financial Statements

Financial Results

CFO Resignation

Management Change

Corporate Restructuring

Agreement Termination

Compliance Waiver

Director Resignation

Financial Results

Financial Restatement

Financial Restatement

External Links:

On May 21, 2026, Adagio Medical Holdings, Inc. announced it submitted a premarket approval application to the FDA for its vCLAS® Ventricular Ablation System intended to treat Ventricular Tachycardia.

AI Assistant

ADAGIO MEDICAL HOLDINGS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.